HR 5381
116th Congress
House
Health
Consumer affairs
Drug safety, medical device, and laboratory regulation
Prescription drugs
International Pharmaceutical Transparency Act of 2019
Introduced: December 10, 2019
Introduced by:
DesJarlais, Scott
Republican
· Tennessee
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 11, 2019
Referred to the Subcommittee on Health.
Dec 10, 2019
Referred to the House Committee on Energy and Commerce.
Dec 10, 2019
Introduced in House
Plain-English summary
International Pharmaceutical Transparency Act of 2019
This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2